News

iZafe Group (publ.) hereby announces that the partner Hepro AS has now starting implementation of 5 Dosell in a municipality in the northern region of Norway. The municipality, which has about 640 inhabitants who are 65 years and older, initially starts...

iZafe Group (publ.) hereby announces that the partner Zafe Care Systems AB has now begun implementation of 5 Dosell in a municipality in southern Sweden. The municipality, which has about 4,350 inhabitants who are 65 years and older, initially starts...

iZafe Group (publ.) hereby announces that the partner Zafe Care Systems AB has now begun implementation of 10 Dosell in a municipality in southern Sweden. The municipality, which has about 6,700 inhabitants who are 65 years and older, initially starts...

iZafe Group (publ.) hereby announces that the increased market investments have yielded good results. Already in the first week of TV advertising, the 50 Dosells the pharmacy had in stock on apoteket.se were sold. Today, new Dosells were shipped Dosells...

iZafe Group AB (publ.) - today Febuary 18, releases its Q4 Interim Report. Summary of financial performance Important events in the quarter Comments from the CEO This has meant that during the fourth quarter we increased production significantly and produced...

iZafe Group (publ.) hereby announces that our partner Zafe Care Systems AB has signed an agreement with a municipality in western Scania. The agreement starts with ten Dosell and implementation takes place at the time of writing. After that, it will be...

iZafe Group AB (publ.) - hereby announces that our partner Zafe Care Systems AB has signed an agreement with a municipality in Västmanland. The municipality will initially start with two medication robots to ensure processes and routines before several...

iZafe Group AB (publ) - announces that in connection with the quarterly report for the fourth quarter of 2021, which will be published at 08:30 CET on February 18, 2022, shareholders, the media and other stakeholders will have the opportunity to ask questions...

iZafe Group AB (publ.) - announces that since the new Dosell was approved by all partners, 450 Swedish medication robots have been produced and shipped. Our factory, like so many others, was affected by the coronavirus, which led to a near-halt in production...

iZafe Group hereby announces that the partner Careium AB has signed an agreement with a municipality in Skåne, which has chosen to introduce the Swedish made medication robot Dosell in its operations. Contacts Carl-Fredrik Bothén, Chief Marketing...

A video summary from Anders Segerström CEO iZafe Group AB of the year 2021 and an insight into 2022. Here is a summary of the past year 2021 and an insight into 2022 from Anders Segerström, CEO of iZafe. Click on the link HERE to watch the movie...

iZafe Group AB has held a partner interview between Anders Segerström, CEO of iZafe Group AB and Geir Tore Jakobsen, CEO of Hepro AS. In the interview between the companies, we clarify certain issues posed to us and at the same time we provide an...

iZafe Group hereby announces that Careium AB, formerly Doro Care, is ordering forty Dosell medication robots. Careium formerly Doro Care is the market leader with new innovation in Sweden and Norway and one of the leading players in the UK and the Netherlands...

Stockholm, Sweden - iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) - hereby announces that the Municipality of Söderköping is extending the agreement by 12 months and our partner Zafe Care Systems AB. Söderköping continues its...

Stockholm, Sweden - iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) - releases "Nobody wants to take the wrong medicine" (only available in Swedish) a report on pharmaceutical use and safety in medication. The report was made in connection...

Stockholm, Sweden - iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) - hereby announces that the first pharmaceutical robots adapted for the Italian consumer market have now been sent to Sempli Farma in Italy for the pilot project. In October this...

Stockholm, Sweden - iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) - hereby announces that Zafe Care Systems is ordering 50 Dosell and is now initiating offensive marketing activities to bring the pharmaceutical robot to market. Zafe Care Systems...

iZafe Group AB (”iZafe”) has entered into an agreement with Mangold Fondkommission AB (Mangold) as liquidity provider for the iZafe share on Nasdaq First North Growth Market. The purpose of the liquidity provider is to improve the liquidity...

Stockholm, Sweden – iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) - today November 29, releases its Q3 Interim Report. Summary of financial performance • Net sales for the quarter totaled SEK 38 thousand (701). Sales for the quarter...

Hepro AS has last issued a final approval of the new version of Dosell and has officially approved the pharmaceutical robot in its entirety for the Norwegian market. As Dosell is a medical technology product that requires high security and functionality...

Stockholm, Sweden, iZafe Group AB (publ) ("iZafe" or "the Company") announces the opportunity for shareholders, media, and other stakeholders to ask company-related questions in connection with its third quarter report. The report...